Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-4-1
pubmed:abstractText
Previous studies related impaired myocardial microcirculation in diabetes to oxidative stress and endothelial dysfunction. Thus, this study was aimed to determine the effect of up-regulating pAMPK-pAKT signaling on coronary microvascular reactivity in the isolated heart of diabetic mice. We measured coronary resistance in wild-type and streptozotocin (STZ)-treated mice, during perfusion pressure changes. Glucose, insulin, and adiponectin levels in plasma and superoxide formation, NOx levels and heme oxygenase (HO) activity in myocardial tissue were determined. In addition, the expression of HO-1, 3-nitrotyrosine, pLKB1, pAMPK, pAKT, and peNOS proteins in control and diabetic hearts were measured. Coronary response to changes in perfusion pressure diverged from control in a time-dependent manner following STZ administration. The responses observed at 28 weeks of diabetes (the maximum time examined) were mimicked by L-NAME administration to control animals and were associated with a decrease in serum adiponectin and myocardial pLKB1, pAMPK, pAKT, and pGSK-3 expression. Cobalt protoporphyrin treatment to induce HO-1 expression reversed the microvascular reactivity seen in diabetes towards that of controls. Up-regulation of HO-1 was associated with an increase in adiponectin, pLKB1, pAKT, pAMPK, pGSK-3, and peNOS levels and a decrease in myocardial superoxide and 3-nitrotyrosine levels. In the present study we describe the time course of microvascular functional changes during the development of diabetes and the existence of a unique relationship between the levels of serum adiponectin, pLKB1, pAKT, and pAMPK activation in diabetic hearts. The restoration of microvascular function suggests a new therapeutic approach to even advanced cardiac microvascular derangement in diabetes.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1097-4644
pubmed:author
pubmed:copyrightInfo
Copyright 2010 Wiley-Liss, Inc.
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
109
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1033-44
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20108250-AMP-Activated Protein Kinases, pubmed-meshheading:20108250-Adiponectin, pubmed-meshheading:20108250-Animals, pubmed-meshheading:20108250-Blood Glucose, pubmed-meshheading:20108250-Body Weight, pubmed-meshheading:20108250-Chronic Disease, pubmed-meshheading:20108250-Diabetes Mellitus, Experimental, pubmed-meshheading:20108250-Glucose Tolerance Test, pubmed-meshheading:20108250-Heme Oxygenase-1, pubmed-meshheading:20108250-Injections, Intraperitoneal, pubmed-meshheading:20108250-Insulin, pubmed-meshheading:20108250-Mice, pubmed-meshheading:20108250-Microcirculation, pubmed-meshheading:20108250-Microvessels, pubmed-meshheading:20108250-Myocardial Ischemia, pubmed-meshheading:20108250-Myocardium, pubmed-meshheading:20108250-Phosphorylation, pubmed-meshheading:20108250-Pressure, pubmed-meshheading:20108250-Protein-Serine-Threonine Kinases, pubmed-meshheading:20108250-Protoporphyrins, pubmed-meshheading:20108250-Signal Transduction, pubmed-meshheading:20108250-Streptozocin, pubmed-meshheading:20108250-Superoxides, pubmed-meshheading:20108250-Time Factors, pubmed-meshheading:20108250-Up-Regulation, pubmed-meshheading:20108250-Vascular Resistance
pubmed:year
2010
pubmed:articleTitle
Improved myocardial perfusion in chronic diabetic mice by the up-regulation of pLKB1 and AMPK signaling.
pubmed:affiliation
CNR Institute of Clinical Physiology, Pisa, Italy. kusmic@ifc.cnr.it
pubmed:publicationType
Journal Article, In Vitro, Research Support, N.I.H., Extramural